Study of a Potential Cancer Treatment Compound
Author Information
Author(s): D. H. Marrian, D. R. Maxwell
Primary Institution: Department of Radiotherapeutics, University of Cambridge
Hypothesis
Can a non-toxic compound selectively concentrate in tumor tissue and increase sensitivity to X-rays?
Conclusion
The compound tetrasodium 2-14C-methyl-1:4-naphthohydroquinone diphosphate concentrates in tumor tissue and shows potential as a radiosensitizer.
Supporting Evidence
- The compound was found to increase the survival time of patients undergoing X-ray therapy for inoperable lung carcinoma.
- About 30% of the injected activity was excreted in the urine within 90 minutes.
- The compound concentrates more in tumor tissue than in muscle for short periods after injection.
Takeaway
Researchers are looking for a special medicine that can help cancer cells be more affected by X-rays, and they found one that seems to work better in tumors.
Methodology
The study involved injecting a radioactive compound into rats and measuring its distribution in various tissues and excretion.
Limitations
The study may not account for all the radioactivity due to difficulties in homogenizing and sampling the carcass.
Participant Demographics
Laboratory stock albino male rats bearing Walker 256 carcinoma.
Want to read the original?
Access the complete publication on the publisher's website